Prostate Cancer Treatment in India: Surgery, Radiation & Hormone Therapy Costs (2026)

Prostate cancer is the second most common cancer in men worldwide. And timely treatment not only effectively manages the illness but also enhances the patient's overall quality of life. In this article, we shall shed light on the various treatment methods for prostate cancer in India and abroad and their projected costs in 2026. As India combines high-quality healthcare with modern medical infrastructure and leading doctors and at the same time the cost of treatment is very low, it has become a favourite place for prostate cancer treatment. Operative procedures, radiation, and hormone therapy still constitute the main modes of cancer treatment. The determinants that influence the choice of the treatment method are the degree of cancer, the health condition of the patient, and the doctor's recommendations. Knowing the costs of these various therapies is also very helpful to patients and their families when deciding on the course of treatment.

Prostate Cancer Treatment in India: All Options Explained

Active surveillance criteria

Active surveillance is usually the first choice for patients diagnosed with very low-risk or low-risk prostate cancer. Instead of rushing into treatments like surgery or radiation, this strategy is basically just careful tracking of the cancer through many methods like checking PSA (prostate-specific antigen), doing the DRE (digital rectal examination), more MRI scans, and also taking biopsies of the prostate at certain intervals. The intention behind this is to prevent or at least postpone the side effects of treatments while at the same time not missing the right moment for cancer therapy if it gets worse.

Having the status of patient under active surveillance means being suitable for the cancer being localized, not very aggressive, and without a high risk of quickly spreading. Usual eligibility criteria include your PSA level being under 10 ng/mL, the tumor's Gleason Grade Group being 1 (Gleason score 3+3=6), clinical T1c or T2a stage of the disease, and a very low percentage of cancer-infected cores on biopsy. For most patients with low-risk (Gleason score ≤ 6) localized prostate cancer, active surveillance is the recommended disease management strategy. 1 Apart from that, patients need to be fit for at least 10 years and willing to be very consistent with their check-ups. On top of that, men with favourable intermediate-risk prostate cancer may be considered for surveillance but only after very careful checking. The most obvious benefit that a patient gets by choosing the route of active surveillance is that they get to keep a high quality of life. Most men will never experience the urinary incontinence, erectile dysfunction, or bowel complications that are the side effects of surgery or radiation therapy.

Leading Indian cancer centres are progressively implementing active surveillance, backed by modern imaging instrumentation and monitoring protocols. For the right patients, it strikes a good compromise between preserving the quality of life and achieving effective cancer control.

Radical prostatectomy (open vs. robotic)

Radical prostatectomy is a surgery aimed at completely removing the prostate gland and the prostate cancer-affected tissues around it. This is a very effective treatment option for men diagnosed with localized or locally advanced prostate cancer, In particular when the cancer is limited to the prostate and hasn't spread to other organs. The key objective of the surgery is to eliminate the cancer completely while also maintaining the patient's urinary continence and sexual function as much as possible.

Radical prostatectomy can be carried out in two main ways: through an open radical prostatectomy or robotic-assisted radical prostatectomy (RARP). With an open surgery, the surgeon makes one large cut in the lower part of the belly, through which the prostate gland is removed. This method has been around for many years and has been a great success, and it forms a dependable choice, mainly in hospitals that do not have robotic systems. The open surgery allows the surgeon to see the area directly and use their sense of touch, which for some expert surgeons is a big plus. On the downside, the open surgery means a bigger cut, more blood loss, a higher level of pain after the operation, and a longer time to feel fully well again.

Robotic-assisted radical prostatectomy is very much in demand in India from the breakthrough in surgical technology. Here, the surgeon moves the robotic tools in several small cuts while staying at a distant console. The robot gives the surgeon a greatly detailed 3D highly visual image, as well as the ability to be very accurate, which in turn helps in gently separating the areas where the nerves and blood vessels lie. So, in many ways, the use of a robot in doing the surgery gives results like drastically less blood loss, lower chance of having to get a transfusion, reduced pain post-surgery, fewer days kept in the hospital, as well as getting back to normal quickly.

Recent studies confirmed lower blood loss, transfusion rates and shorter catheterization time for robot-assisted radical prostatectomy (RARP) compared with open radical prostatectomy (ORP). 

Robotic prostatectomy in India is found mainly in tertiary-care and oncology hospitals which are very often situated in or around big cities. As a rule, it is costlier than the open method because of the very expensive robotic devices and their upkeep. Patients are advised to have a thorough talk with their doctors about the pros and cons, effectiveness, and the financial aspects of the methods before making the final decision.

HIFU & Cryotherapy — minimally invasive options

 Some types of ablative treatments, such as cryotherapy and high-intensity focused ultrasound (HIFU), might be options to treat prostate cancer in certain situations, such as after radiation therapy.3 High-Intensity Focused Ultrasound (HIFU) and cryotherapy have become two of the most interesting forms of minimally invasive treatments in the field of prostate cancer without surgery or radiation.

These methods focus on eradicating only cancerous tissue, while the destruction of normal cells is kept to a minimum, and so the patient's recovery period may be shortened, and the overall quality of life may be kept at a satisfactory level.

On the principle level, HIFU works by directing ultrasound waves that are very focused to such an extent that they will produce heat that is very high in the prostate glands. Heat is the factor that eventually kills cancer cells, and this is done without the opening of the patients' body. Normally the patient will also receive some form of anesthesia and for most of them the discharge will happen on the same day or if hospital admission was required it will only be for a very short time. HIFU is usually aimed at men who have been diagnosed with localized, low, or medium-risk prostate cancer and even those whose prostate cancer has come back after radiotherapy. Given that only targeted regions of the prostate receive treatment, HIFU will be less likely to have side effects compared to conventional treatment. Still, proof of HIFU's effectiveness in cancer control over time is not as substantial as that of surgery or radiation therapy.

Another way to get rid of prostate cancer cells is cryotherapy, or freezing them. Thin needles are introduced into the prostate gland while the patient is being scanned. Cooled gases travel down the needles, causing ice balls to form that are capable of freezing and killing cancer cells. Cryotherapy is also capable of being used as a first treatment for localized prostate cancer or as a backup when cancer returns after the patient has undergone radiation treatment. In the same manner as HIFU cryotherapy is the least traumatic to the patient and usually, the patient will not be disposed to the risks of the major surgical procedure for the longer duration of the recovery period.

In India, besides comprehensive treatment offerings, HIFU and cryotherapy are becoming increasingly available, mainly in major metropolitan areas with highly specialized urology and oncology departments. 

Radiation & brachytherapy for prostate

Radiation and brachytherapy for prostate cancer is a very effective radiation therapy option, and the two can control cancer just as well as surgery while maintaining the prostate. Late-stage radiation treatment can be good for men who can't have surgery, who want to avoid surgery, or who have other features that make radiation treatment the right option. The newest radiation methods have become very accurate, so they harm the surrounding normal tissues less and the side effects get less.

One way of doing radiation is to use radioactive beams that kill cancer cells and stop new ones from being made. External beam is the usual type of radiation therapy, where the radiation comes from a machine outside the patient. There are also upgraded types of radiation like IMRT, IGRT, and SBRT that can target the tumor very precisely. These methods make it possible to give less radiation to organs close to the tumor, like the bladder and rectum, so there is less risk of complications. Treatment can be done daily for a few weeks or fewer times in a few days, according to the method used.

Brachytherapy or internal radiation treatment works by putting the radioactive material inside or very close to the prostate gland giving a very high dose to the tumor while sparing surrounding tissues from high doses. There are two main kinds of brachytherapy: low-dose-rate (LDR) where radioactive particles are permanently left in the prostate and high-dose-rate (HDR) where the radioactive particles are temporary put in and then taken out. Brachytherapy can be a single treatment for low-risk prostate cancer or local radiation can be added for high-risk disease.

For patients with intermediate-risk prostate cancer choosing EBRT with or without androgen-deprivation therapy, brachytherapy boost (LDR or HDR) should be offered to eligible patients4.

Indian treatment centers providing advanced radiation therapies and brachytherapy are not only affordable for local people but also attract many foreign patients. Multi-disciplinary consultation ensures that the patient gets proper radiation treatment.

Cost Comparison for Prostate Cancer Treatment

Robotic prostatectomy: $9,000–$13,000 in India vs. $50,000+ in US

Using robotics in prostatectomy surgery is now among the most advanced options for treating localized prostate cancer. A robotic-assisted surgical system allows surgeons to perform extremely precise movements through very small incisions. Compared to conventional open surgery, robotic prostatectomy has many benefits including really less blood loss, lower levels of pain after surgery, shorter stays in hospital, and quicker recovery times. Although the technology and the surgical results achieved by the top international centres are similar, the cost of treatment differs greatly from one country to another, which is the main reason why medical tourists are viewing India more and more as a destination for such treatment.

Generally, the cost of a robotic prostatectomy in India may be between $9,000 and $13 000 given various factors like the fame of the hospital, skill of the surgeon, city, type of room, as well as how complicated the case is. This cost usually covers surgeon's fees, anaesthesia charges, operation room expenses, hospital stay, nursing care, medicines during the stay, and routine follow-up after the surgery. Many hospitals provide all-inclusive packages for international patients which besides medical treatment may also include airport pick-up and drop, help with accommodation, language interpretation, and care coordination.

On the contrary, the price of a robotic prostatectomy in the U. S. alone is often more than $50,000; the total cost can be $70,000 or even higher. This higher price is due to higher salaries for healthcare workers, costs of administration, insurance-related costs, facility fees, as well as the ways in which doctors are paid. A patient with insurance might still have to pay quite a bit from their own pocket through deductibles, copayments, and coinsurance. For those without insurance, the financial burden can be very heavy.

Even with a big cost difference, a lot of Indian hospitals still provide the care of an international standard. The big cancer and multispecialty hospitals have cutting-edge robotic surgical units and the surgeons who operate with these machines have received their training at a very advanced level in robotic urologic oncology. That means, measures like how well patients are cured of cancer, regaining continence, and keeping erectile function can also be on the same level as that of top centres in North America and Europe if the patients are well-chosen.

Frequently Asked Questions

1Q: Is HIFU available for prostate cancer in India?

Ans: Really, High-Intensity Focused Ultrasound (HIFU) is offered in India for few patients with localized prostate cancer. This technique works with ultrasound waves which are tuned very accurately to kill cancer cells and tumors. Main cancer hospitals in different parts of India including Mumbai Delhi Chennai, and Bengaluru have facilities of HIFU. Since it is a minimal invasive surgery and patient does not have a major surgery, usually recovery time is very less and it may also help in converting urinary and sexual functions in right cases.

2Q: What is the cure rate for prostate cancer in India?

Ans: Prostate cancer cure rate in India varies with the stage at diagnosis and treatment given. For localized prostate cancer (prostate only), 5-year survival rate is more than 95% in most cases, and surgery or radiation can cure the patient in many instances. When detected early, the best long-term survival rate can be as high as 98-100%. There are fewer cures for advanced or metastatic prostate cancer. Still, in many cases, the patients can live quite a few years with proper treatment. 

3Q: Which is better for prostate cancer: surgery or radiation therapy?

Ans: For localized disease, radiotherapy and surgery are equally effective in a large proportion of patients, with similar long-term control rates for prostate cancer. Surgery is often the primary treatment for younger healthier patients and an insight into tumor characteristics can be gained via the pathology report. Brachytherapy (implant) may be more suitable for older patients. The target for treatment depends upon age stage health status and individual preference following discussion with a urologist.